Eczema screening: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
|||
Line 115: | Line 115: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[category:needs english review]] | |||
[[ |
Revision as of 19:44, 4 July 2022
Eczema Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Eczema On the Web |
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Hanifin and Rajka criteria are the gold standard for diagnosing eczema. [1] [2]
Eczema screening
- Hanifin and Rajka criteria are the gold standard for diagnosing eczema.
- It should satisfy 3 out of 4 major criteria, or 3 out of 23 minor criteria. [3]
References
- ↑ Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL; et al. (2014). "Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis". J Am Acad Dermatol. 70 (2): 338–51. doi:10.1016/j.jaad.2013.10.010. PMC 4410183. PMID 24290431.
- ↑ Schulte-Herbrüggen O, Fölster-Holst R, von Elstermann M, Augustin M, Hellweg R (2007). "Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis". Int Arch Allergy Immunol. 144 (3): 211–6. doi:10.1159/000103994. PMID 17579279.
- ↑ Avena-Woods C (2017). "Overview of atopic dermatitis". Am J Manag Care. 23 (8 Suppl): S115–S123. PMID 28978208.